Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...

Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

Medications such as Ozempic and Saxenda have grown in popularity due to their ability to treat type 2 diabetes and assist in weight loss. These medications belong to a class of drugs known as GLP-1 ...

People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

Ozempic, which is prescribed for diabetes, and Wegovy, prescribed for weight loss, both contain the active ingredient ...

The unexpected ways Ozempic-like drugs might fight dementia. They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...